Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0JBYDO
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
WO2014159981A2 ADC-SLC34A2-33
|
|||||
| Synonyms |
WO2014159981A2 ADC-SLC34A2-33
Click to Show/Hide
|
|||||
| Organization |
ADC Therapeutics SA; Genentech, Inc.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 2 Indication(s)
Lung cancer [ICD11:2C25]
Investigative
Ovarian cancer [ICD11:2C73]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1.4
|
|||||
| Structure |
|
|||||
| Antibody Name |
Thio hu Anti-Napi3b 10H1.11.4B HC A118C
|
Antibody Info | ||||
| Antigen Name |
Sodium-dependent phosphate transport protein 2B (SLC34A2)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
WO2014159981A2_ADC-SLC34A2-33 linker
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.